Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL ยท Real-Time Price ยท USD
0.9466
-0.0391 (-3.97%)
At close: Nov 20, 2026, 4:00 PM EST
0.9500
+0.0034 (0.36%)
After-hours: Nov 20, 2026, 7:30 PM EST
Werewolf Therapeutics Revenue
Werewolf Therapeutics had revenue of $21.00M in the twelve months ending September 30, 2026. That makes Werewolf Therapeutics the 33,622nd largest company in the world by revenue and 4,402nd in the United States.
Revenue (ttm)
$21.00M
Revenue Growth
n/a
P/S Ratio
2.19
Revenue / Employee
$1,500,000
Employees
14
Market Cap
46.00M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 1.89M | -18.06M | -90.55% |
| Dec 31, 2023 | 19.94M | 3.54M | 21.60% |
| Dec 31, 2022 | 16.40M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Heron Therapeutics | 148.22M |
| Tonix Pharmaceuticals Holding | 43.05M |
| Spero Therapeutics | 41.56M |
| Verrica Pharmaceuticals | 22.89M |
| RenovoRx | 2.78M |
| ImageneBio | 800.00K |
HOWL News
- 9 days ago - Werewolf Therapeutics Quarterly report: Q3 2026 - Filings
- 12 days ago - Werewolf Therapeutics announces new clinical data from WTX-124 trial - TheFly
- 12 days ago - Werewolf Therapeutics' Clinical Data for WTX-124 and WTX-330 Presented at the Society for Immunotherapy of Cancer's (SITC) 2026 Annual Meeting - GlobeNewsWire
- 22 days ago - Werewolf Therapeutics Selected for Oral Presentation and to Present Posters at the Society for Immunotherapy of Cancer's (SITC) 2026 Annual Meeting - GlobeNewsWire
- 1 month ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq โ HOWL), Beazer Homes USA, Inc. (NYSE โ BZH), Lantheus Holdings Inc. (Nasdaq โ LNTH), MarketAxess Holdings Inc. (Nasdaq โ MKTX) - GlobeNewsWire
- 2 months ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq โ PSNL), Werewolf Therapeutics, Inc. (Nasdaq โ HOWL), Beazer Homes USA, Inc. (NYSE โ BZH), MarketAxess Holdings Inc. (Nasdaq โ MKTX) - GlobeNewsWire
- 2 months ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq โ HOWL), Beazer Homes USA, Inc. (NYSE โ BZH), MarketAxess Holdings Inc. (Nasdaq โ MKTX), CBIZ, Inc. (NYSE โ CBZ) - GlobeNewsWire
- 3 months ago - Why Werewolf Therapeutics stock exploded higher and what comes next? - Invezz